background
littl
known
preval
viral
infect
children
communityacquir
pneumonia
cap
object
describ
clinic
virolog
data
collect
children
radiograph
confirm
cap
respiratori
virus
sought
respiratori
secret
sampl
acut
phase
diseas
patient
method
studi
involv
children
radiograph
confirm
cap
whose
respiratori
secret
sampl
test
use
luminex
xtag
respiratori
viru
panel
fast
assay
simultan
detect
influenza
viru
influenza
b
viru
respiratori
syncyti
viru
rsv
b
adenoviru
human
metapneumoviru
coronavirus
enteroviru
rhinoviru
bocaviru
realtim
pcr
assay
use
identifi
rhinoviru
enteroviru
rhinovirusposit
sampl
result
total
children
posit
least
one
viru
frequent
detect
rsv
found
follow
rhinoviru
n
bocaviru
n
influenza
virus
n
hmpv
n
viral
coinfect
found
children
enrol
children
viral
infect
margin
differ
found
infect
owe
singl
viru
coinfect
show
radiograph
evid
alveolar
pneumonia
significantli
frequent
singl
infect
ci
conclus
find
studi
highlight
import
respiratori
virus
mainli
rsv
rhinoviru
children
cap
show
characterist
singl
infect
coinfect
associ
diseas
despit
develop
effect
antimicrobi
therapi
manag
guidelin
effect
vaccin
communityacquir
pneumonia
cap
remain
one
major
caus
morbid
children
live
develop
countri
one
main
caus
mortal
live
develop
world
detail
inform
concern
etiolog
cap
requir
order
formul
treatment
recommend
implement
prevent
measur
evalu
rel
import
potenti
pathogen
may
also
contribut
improv
understand
pathogenesi
diseas
virus
long
consid
predomin
pathogen
cap
particularli
infant
children
age
year
howev
limit
sensit
specif
previou
virolog
diagnost
techniqu
base
cultur
immunofluoresc
microscopi
measur
antibodi
respons
pair
serum
sampl
consider
number
cap
case
etiolog
identifi
recent
advanc
molecular
diagnosi
made
possibl
detect
previous
unknown
viral
agent
defin
epidemiolog
common
respiratori
viral
infect
precis
still
mani
unansw
question
concern
role
virus
pediatr
cap
littl
known
real
preval
viral
infect
particularli
identifi
recent
frequenc
import
viral
coinfect
fulli
clarifi
order
answer
question
need
studi
use
method
allow
identif
greatest
number
potenti
viral
respiratori
pathogen
aim
studi
describ
data
collect
children
radiograph
confirm
cap
respiratori
virus
detect
respiratori
secret
sampl
use
luminex
xtag
respiratori
viru
panel
rvp
fast
assay
acut
phase
diseas
studi
approv
institut
review
board
fondazion
ircc
ca
granda
ospedal
maggior
policlinico
milan
itali
carri
depart
matern
pediatr
scienc
univers
milan
novemb
april
four
consecut
winter
earli
spring
season
written
inform
consent
parent
legal
guardian
requir
older
children
ask
give
assent
children
age
month
year
seen
emerg
room
er
depart
matern
pediatr
scienc
fever
axillari
temperatur
sign
symptom
consist
cap
ie
cough
tachypnea
dyspnea
respiratori
distress
breath
grunt
wheez
sound
rale
consid
elig
studi
exclus
criteria
chronic
diseas
increas
risk
respiratori
infect
includ
prematur
birth
chronic
disord
pulmonari
cardiovascular
system
includ
asthma
chronic
metabol
diseas
includ
diabet
mellitu
neoplasia
kidney
liver
dysfunct
hemoglobinopathi
immunosuppress
diseas
requir
longterm
aspirin
therapi
genet
neurolog
disord
children
presum
nosocomi
cap
ie
appear
hour
admiss
within
week
hospit
discharg
also
exclud
chest
xray
evalu
independ
expert
radiologist
classifi
find
alveolar
pneumonia
nonalveolar
pneumonia
pneumonia
accord
world
health
organ
criteria
standard
interpret
pediatr
chest
radiograph
diagnosi
pneumonia
alveolar
pneumonia
defin
dens
opac
appear
fluffi
consolid
part
lobe
entir
lung
often
contain
air
reveal
bronchographi
sometim
associ
pleural
effus
respiratori
secret
sampl
taken
enrol
children
radiograph
confirm
cap
use
pernas
nylon
flock
swab
store
tube
utmrt
cat
copan
italia
brescia
itali
upon
enrol
detail
inform
regard
demograph
data
clinic
histori
clinic
characterist
diseas
collect
togeth
blood
sampl
evalu
laboratori
variabl
includ
white
blood
cell
count
creactiv
protein
crp
blood
cultur
drug
treatment
chosen
pediatrician
charg
basi
guidelin
italian
societi
pediatr
children
mild
diseas
sent
home
detail
therapeut
instruct
recommend
return
hospit
case
persist
fever
worsen
respiratori
symptom
sign
children
sever
diseas
famili
problem
hospit
clinic
data
collect
hospit
record
daili
children
whether
hospit
sent
home
immedi
enrol
reevalu
day
later
mean
interview
clinic
examin
carri
train
investig
use
standard
questionnair
also
collect
inform
regard
household
ill
relat
morbid
viral
rna
dna
extract
respiratori
secret
mean
nuclisen
easymag
autom
extract
system
craponn
franc
test
use
luminex
xtag
respiratori
viru
panel
rvp
fast
assay
accord
manufactur
instruct
luminex
molecular
diagnost
inc
toronto
canada
xtag
rvp
fast
reagent
provid
abbott
gmbh
co
wiesbadendelkenheim
germani
rvp
fast
assay
consist
singl
multiplex
polymeras
chain
reaction
pcr
label
primer
follow
singlestep
hybrid
pcr
product
fluoresc
bead
array
incub
reagent
plate
analyz
use
bioplex
system
biorad
laboratori
milan
itali
associ
softwar
luminex
xponent
version
luminex
molecular
diagnost
inc
provid
abbott
median
fluoresc
intens
mfi
determin
mfi
threshold
level
determin
manufactur
particular
target
indic
posit
result
target
mean
fluoresc
intens
establish
posit
establish
use
tagit
data
analysi
softwar
tda
luminex
rvp
fast
assay
simultan
detect
influenza
viru
subtyp
influenza
b
viru
respiratori
syncyti
viru
rsv
b
adenoviru
human
metapneumoviru
hmpv
coronavirus
enteroviru
rhinoviru
human
bocaviru
assay
also
test
intern
posit
control
ad
specimen
extract
stage
escherichia
coli
phage
rna
posit
run
control
ad
plate
bacteriophag
lambda
dna
enteroviru
rhinovirusposit
sampl
retest
order
identifi
rhinoviru
realtim
pcr
assay
perform
use
iagpathid
onestep
rtpcr
kit
appli
biosystem
foster
citi
ca
usa
primer
probe
sequenc
report
lu
et
al
briefli
reaction
mixtur
contain
lm
forward
revers
primer
lm
probe
nucleic
acid
extract
amplif
perform
use
ht
fast
realtim
pcr
detect
system
appli
biosystem
follow
thermocycl
condit
min
rt
min
polymeras
activ
cycl
second
minut
run
includ
templat
nontempl
control
descript
statist
gener
continu
variabl
given
mean
valu
standard
deviat
sd
analyz
use
twosid
nonparametr
wilcoxon
rank
sum
test
data
normal
distribut
basi
shapirowilk
statist
twosid
student
ttest
categor
variabl
given
absolut
number
percentag
compar
group
use
conting
tabl
analysi
chisquar
test
fisher
exact
test
appropri
odd
ratio
or
confid
interv
ci
calcul
measur
associ
posit
select
virus
presenc
fever
ii
hospit
iii
presenc
rale
iv
presenc
wheez
v
rel
similar
ill
vi
radiolog
evid
alveolar
pneumonia
or
obtain
use
uncondit
multipl
logist
regress
analysi
adjust
age
year
gender
also
analyz
associ
presenc
one
viral
infect
clinic
radiolog
characterist
adjust
age
gender
analys
made
use
sa
version
cari
nc
usa
year
studi
children
boy
mean
age
sd
year
radiograph
confirm
cap
posit
least
one
viru
virus
detect
children
age
year
age
year
age
year
p
versu
year
year
age
group
nine
children
neg
respiratori
virus
posit
blood
cultur
six
streptococcu
pneumonia
two
staphylococcu
aureu
one
nontyp
haemophilu
influenza
preliminari
analysi
preval
respiratori
virus
show
statist
signific
differ
year
sampl
collect
data
collect
year
consid
togeth
tabl
show
viral
find
age
group
presenc
viralvir
coinfect
frequent
detect
viru
rsv
found
children
follow
rhinoviru
n
bocaviru
n
influenza
virus
n
six
season
eight
b
pandem
hmpv
n
coronavirus
n
five
five
three
enteroviru
n
adenoviru
n
parainfluenza
virus
n
seven
one
one
one
among
children
age
year
rhinoviru
common
caus
infect
studi
virus
found
isol
agent
coinfect
incid
coinfect
decreas
age
significantli
lower
children
age
year
age
year
p
year
p
viru
caus
highest
percentag
coinfect
involv
coronaviru
found
togeth
virus
children
follow
bocaviru
parainfluenza
virus
adenoviru
enteroviru
rhinoviru
rsv
hmpv
influenza
virus
tabl
summar
viral
coinfect
found
children
enrol
children
viral
infect
infect
two
three
one
four
virus
common
coinfect
involv
rsv
rhinoviru
case
rhinoviru
bocaviru
case
rsv
coronaviru
case
rsv
bocaviru
case
tabl
describ
characterist
cap
associ
singl
viral
infect
order
abl
evalu
suffici
substanti
number
compar
singl
infect
detect
least
case
analysi
differ
infect
owe
rsv
rhinoviru
influenza
hmpv
bocaviru
show
mean
age
children
rsvposit
cap
significantli
lower
rhinovirusor
influenzaposit
cap
p
highgrad
fever
significantli
frequent
among
children
hmpvposit
cap
among
rhinovirusposit
cap
p
rale
significantli
frequent
among
children
rsv
hmpv
bocavirusposit
cap
among
rhinovirusposit
cap
p
influenzaposit
cap
case
show
similar
diseas
among
famili
member
significantli
often
rhinovirusand
bocavirusposit
case
p
betweengroup
differ
term
clinic
present
outcom
among
laboratori
paramet
crp
level
significantli
higher
rhinovirusposit
case
rsvand
influenzaposit
case
p
differ
white
blood
cell
count
relat
radiograph
find
alveolar
pneumonia
significantli
frequent
rhinovirusposit
case
influenzaand
hmpvposit
case
p
multivari
analysi
show
rhinovirusposit
case
significantli
less
frequent
associ
fever
ci
rale
ci
similar
ill
among
famili
member
ci
rhinovirusneg
case
contrari
hmpvposit
case
significantli
frequent
associ
fever
ci
hmpvneg
case
influenzaposit
case
significantli
frequent
associ
similar
ill
among
famili
member
ci
significantli
less
frequent
associ
alveolar
pneumonia
ci
influenzaneg
case
tabl
show
demograph
clinic
laboratori
radiograph
variabl
associ
singl
viral
infect
coinfect
signific
differ
mean
age
significantli
higher
children
singl
viral
infect
coinfect
p
radiograph
find
alveolar
pneumonia
significantli
frequent
children
coinfect
p
multivari
analysi
show
signific
associ
significantli
frequent
radiograph
evid
alveolar
pneumonia
children
coinfect
singl
infect
ci
use
combin
two
molecular
method
identifi
virus
upper
respiratori
tract
secret
order
evalu
relationship
viral
infect
rsv
respiratori
syncyti
viru
hmpv
human
metapneumoviru
p
versu
age
group
year
blackwel
publish
ltd
develop
cap
consider
number
otherwis
healthi
infant
children
enrol
larg
number
pediatr
patient
facilit
use
pernas
nylon
flock
swab
significantli
less
invas
nasopharyng
aspir
wash
valid
altern
mean
collect
secret
detect
respiratori
virus
particularli
use
molecular
assay
best
knowledg
evalu
respiratori
virus
includ
recent
identifi
virus
children
cap
ever
thu
improv
understand
role
individu
virus
viral
coinfect
data
confirm
import
virus
determin
pediatr
cap
previous
highlight
number
author
also
suggest
virus
may
play
even
greater
role
previous
thought
children
viral
respiratori
infect
includ
age
month
previou
studi
alway
found
lower
percentag
therefor
underestim
real
import
virus
pediatr
cap
probabl
sought
smaller
number
virus
rsv
rhinoviru
common
pathogen
associ
cap
form
singl
viral
infect
coinfect
found
alon
case
thu
highlight
role
caus
pediatr
cap
underlin
need
develop
safe
effect
vaccin
order
face
clinic
problem
may
give
rise
seem
particularli
import
case
rhinoviru
year
ago
consid
rel
import
rare
associ
cap
usual
includ
evalu
cap
etiolog
frequent
identifi
recent
discov
virus
bocaviru
hmpv
data
regard
bocaviru
quit
similar
report
fri
et
al
et
al
found
children
cap
respect
thailand
itali
howev
observ
studi
mainli
found
associ
virus
often
detect
singli
particularli
rsv
rhinoviru
suggest
bocaviru
may
play
primari
role
caus
cap
presenc
respiratori
secret
owe
previou
infect
follow
prolong
lowlevel
viral
shed
furthermor
previou
studi
children
respiratori
diseas
bocaviru
infect
found
sever
clinic
pictur
diagnos
children
suffer
coinfect
wherea
case
associ
singl
bocaviru
infect
mild
role
play
hmpv
seem
import
overal
frequenc
quit
similar
bocaviru
detect
associ
virus
case
quit
similar
found
wolf
et
al
studi
carri
israel
suggest
viru
may
play
direct
pathogen
role
develop
cap
influenza
virus
fourth
frequent
detect
infecti
agent
children
cap
show
lowest
incid
coinfect
confirm
import
virus
even
lower
respiratori
tract
infect
underlin
need
annual
vaccin
administr
global
incid
infect
owe
coronavirus
higher
found
larg
pneumonia
studi
carri
thailand
howev
fact
coronavirus
mainli
found
associ
virus
suggest
old
new
virus
rel
import
pediatr
cap
consequ
despit
discoveri
new
coronavirus
effect
prevent
measur
seem
urgent
need
seem
true
case
enteroviru
found
small
number
case
frequent
associ
virus
adenoviru
parainfluenza
viru
identifi
small
number
case
previou
studi
found
frequenc
identifi
adenoviru
vari
although
preval
alway
rel
low
viru
systemat
monitor
associ
sever
fatal
necrotis
pneumonia
incid
parainfluenza
viru
infect
significantli
lower
observ
previou
studi
find
may
least
partial
due
differ
method
use
identifi
virus
fact
look
larger
number
infecti
agent
case
found
associ
virus
thu
suggest
rel
clinic
import
coinfect
common
possibl
defin
precis
role
pathogen
caus
crp
creactiv
protein
rsv
respiratori
syncyti
viru
hmpv
human
metapneumoviru
sd
standard
deviat
spo
peripher
oxygen
satur
p
versu
rhinoviru
p
versu
influenza
p
versu
hmpv
time
ill
time
enrol
followup
time
ill
time
enrol
followup
cap
coinfect
children
howev
although
higher
among
frequent
isol
virus
preval
coinfect
strictli
relat
absolut
preval
individu
virus
higher
case
coronavirus
parainfluenza
virus
enteroviru
adenoviru
rsv
rhinoviru
influenza
virus
even
though
last
detect
significantli
children
find
contrast
hypothesi
cilla
et
al
suggest
percentag
coinfect
owe
viru
owe
circul
comparison
virus
seem
indic
factor
may
play
role
favour
concomit
multipl
viral
infect
subject
interestingli
margin
differ
found
demograph
clinic
laboratori
radiograph
variabl
associ
singl
viral
infect
although
signific
differ
individu
variabl
associ
specif
viru
variabl
data
make
imposs
defin
characterist
pictur
cap
case
associ
viru
furthermor
differ
virus
term
clinic
variabl
indic
diseas
sever
ie
rate
crp
creactiv
protein
sd
standard
deviat
spo
peripher
oxygen
satur
time
ill
enrol
followup
time
ill
enrol
followup
durat
hospit
drug
use
suggest
earli
use
antivir
therapi
cap
case
associ
influenza
virus
limit
absenc
virolog
assay
also
highlight
import
epidemiolog
surveil
use
molecular
least
rapid
test
individu
patient
order
ensur
antivir
drug
use
case
indic
comparison
characterist
singl
viral
infect
coinfect
show
signific
differ
associ
alveolar
pneumonia
viral
coinfect
clinic
laboratori
data
includ
white
blood
cell
count
crp
concentr
suggest
bacteri
superinfect
find
may
explain
synergist
role
one
viru
caus
lung
inflamm
consequ
radiograph
chang
hand
nonalveolar
cap
similarli
preval
alveolar
pneumonia
children
singl
viral
infect
studi
two
limit
first
identifi
virus
upper
respiratori
secret
children
cap
may
indic
realli
involv
caus
diseas
may
indic
coincident
upper
airway
infect
due
carrier
state
prolong
shed
pathogen
caus
previou
infect
howev
virus
gener
detect
asymptomat
subject
although
preval
rhinoviru
high
given
preval
viral
infect
children
highli
like
detect
virus
play
import
pathogen
role
determin
cap
case
howev
demonstr
viral
bacteri
coinfect
common
possibl
cap
case
attribut
virus
us
least
partial
owe
concomit
viral
bacteri
infect
higher
crp
level
greater
frequenc
alveolar
cap
observ
rhinovirusposit
case
rsvand
influenzaposit
case
may
indic
greater
degre
bacteri
involv
viral
infect
systemat
perform
blood
cultur
enrol
children
order
identifi
bacteri
infect
procedur
sensit
case
neg
therefor
possibl
draw
conclus
concern
real
incid
viral
bacteri
coinfect
evalu
import
viru
favour
bacteri
superinfect
hand
although
may
use
cultur
sputum
order
identifi
respiratori
bacteria
respons
cap
decid
import
collect
sputum
children
wide
debat
even
complic
uncomfort
procedur
use
includ
pharmacolog
pretreat
salin
aerosol
nasal
aspir
specimen
consid
adequ
second
limit
relat
fact
studi
conduct
winter
earli
spring
may
overestim
role
infecti
agent
circul
period
underestim
virus
preval
circul
month
organ
er
allow
activ
specimen
collect
cap
case
whole
year
conclus
find
highlight
import
respiratori
virus
mainli
rsv
rhinoviru
pediatr
cap
suggest
recent
discov
respiratori
viru
frequent
associ
cap
singl
infecti
agent
hmpv
show
margin
differ
characterist
singl
viral
infect
demonstr
viral
coinfect
often
associ
alveolar
pneumonia
singl
viral
infect
absenc
differ
clinic
laboratori
paramet
inform
import
manag
pediatr
cap
help
defin
infecti
agent
need
prevent
vaccin
could
develop
